1. Galli M, Porto I, Andreotti F, D’Amario D, Vergallo R, Della Bona R, et al. Early anticoagulation in the current management of NSTE-ACS: evidence, guidelines, practice and perspectives. Int J Cardiol. 2019;275:39–45.
2. Dababneh E, Goldstein S. Chronic ischemic heart disease, selection of treatment modality. StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC.; 2018.
3. Yamada Y, Yasukochi Y, Kato K, Oguri M, Horibe H, Fujimaki T, et al. Identification of 26 novel loci that confer susceptibility to early-onset coronary artery disease in a Japanese population. Biomed Rep. 2018;9(5):383–404.
4. Lu H, Chen Y, Li L. Metabolic pathway genes associated with susceptibility genes to coronary artery disease. Int J Genom. 2018;2018:9025841.
5. Liu B, Pjanic M, Wang T, Nguyen T, Gloudemans M, Rao A, et al. Genetic regulatory mechanisms of smooth muscle cells map to coronary artery disease risk loci. Am J Hum Genet. 2018;103(3):377–88.